Ling-Ming Tseng

15PUBLICATIONS
140CO-AUTHORS
Epidemiological methodsMolecular targetsModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 13, 2026
Factors associated with medication adherence to endocrine therapy in women with breast cancer: an analysis based on temporal self-regulation theory.

|Jul 06, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|Apr 13, 2026
Clinical presentations and prognostication of HER2-low and HER2-zero early breast cancer in Taiwan.

Yen-Jen Chen, Pei-Ju Lien, Ling-Ming Tseng

|Jan 08, 2026
DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer.

Komal Jhaveri, Sherene Loi, Erika Hamilton

|Oct 29, 2025
Multi-gene expression assays in breast cancer: a literature review.

Tsung-Yen Hsieh, Chi-Cheng Huang, Ling-Ming Tseng

|Mar 06, 2025
Treatment Patterns and Outcomes of Young Female Early Breast Cancer in Taiwan.

Chi-Cheng Huang, Ling-Ming Tseng

Pageof 3

Frequent Collaborators

5 joint publications

Chi-Cheng Huang

2 joint publications

Shuh-Jen Sheu

2 joint publications

Shin-Cheh Chen

2 joint publications

Sheng-Miauh Huang